By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Edge Therapeutics 

NJIT-EDC Biotechnology Incubator
139 South Street, Suite 102
New Providence  New Jersey  07974  U.S.A.
Phone: 800-208-EDGE Fax: 800-208-3433



Company News
Edge Therapeutics Appoints Chief Operating Officer And Makes Inducement Grant Under NASDAQ Rule 5635(c)(4) 10/17/2016 7:30:03 AM
Edge Therapeutics To Present At The Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series And Participate In Additional Investor Conferences In September 9/8/2016 8:11:45 AM
Edge Therapeutics Announces Additional Pharmacokinetic Data Supporting The Potential Clinical And Health Economic Impact Of EG-1962 In Aneurysmal Subarachnoid Hemorrhage 9/7/2016 10:09:08 AM
Edge Therapeutics To Present Additional Data From Phase I/II NEWTON Study Of EG-1962 At Two Scientific Conferences In September 9/2/2016 8:19:51 AM
Edge Therapeutics Reports Second Quarter Financial Results And Recent Highlights 8/3/2016 10:21:38 AM
Edge Therapeutics Announces Closing Of $20 Million Debt Facility With Hercules Capital 8/2/2016 8:34:54 AM
Edge Therapeutics Announces First Patient Treated In Phase III NEWTON 2 Study Of EG-1962 In Adult Patients With Aneurysmal Subarachnoid Hemorrhage 7/29/2016 8:12:17 AM
Edge Therapeutics To Host Conference Call On August 3, 2016 To Discuss Second Quarter Financial Results 7/27/2016 8:20:18 AM
Edge Therapeutics To Participate In Guggenheim Securities 3rd Annual Healthcare Conference 12/8/2015 7:38:13 AM
Edge Therapeutics Names W. Bradford Middlekauff As Senior Vice President, General Counsel And Secretary 11/5/2015 9:58:49 AM